Integrated Diagnostics Holdings Past Earnings Performance
Past criteria checks 5/6
Integrated Diagnostics Holdings has been growing earnings at an average annual rate of 3.9%, while the Healthcare industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 14.8% per year. Integrated Diagnostics Holdings's return on equity is 20.6%, and it has net margins of 17.2%.
Key information
3.9%
Earnings growth rate
2.7%
EPS growth rate
Healthcare Industry Growth | 12.6% |
Revenue growth rate | 14.8% |
Return on equity | 20.6% |
Net Margin | 17.2% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around
Nov 07Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?
Oct 17Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)
Jun 22Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit
Nov 25Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?
Sep 06Revenue & Expenses Breakdown
How Integrated Diagnostics Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 4,378 | 755 | 778 | 0 |
31 Dec 23 | 4,123 | 510 | 773 | 0 |
30 Sep 23 | 3,858 | 538 | 780 | 0 |
30 Jun 23 | 3,523 | 342 | 759 | 0 |
31 Mar 23 | 3,340 | 417 | 686 | 0 |
31 Dec 22 | 3,605 | 541 | 619 | 0 |
30 Sep 22 | 4,258 | 716 | 613 | 0 |
30 Jun 22 | 4,886 | 1,188 | 578 | 0 |
31 Mar 22 | 5,276 | 1,383 | 587 | 0 |
31 Dec 21 | 5,225 | 1,413 | 558 | 0 |
30 Sep 21 | 4,753 | 1,322 | 493 | 0 |
30 Jun 21 | 4,000 | 1,062 | 447 | 0 |
31 Mar 21 | 3,286 | 816 | 401 | 0 |
31 Dec 20 | 2,656 | 594 | 371 | 0 |
30 Sep 20 | 2,247 | 523 | 577 | 0 |
30 Jun 20 | 2,115 | 466 | 351 | 0 |
31 Mar 20 | 2,180 | 491 | 388 | 0 |
31 Dec 19 | 2,226 | 511 | 314 | 0 |
30 Sep 19 | 2,193 | 508 | 261 | 0 |
30 Jun 19 | 2,117 | 510 | 285 | 0 |
31 Mar 19 | 2,035 | 518 | 205 | 0 |
31 Dec 18 | 1,921 | 502 | 265 | 0 |
30 Sep 18 | 1,790 | 447 | 186 | 0 |
30 Jun 18 | 1,695 | 435 | 222 | 0 |
31 Mar 18 | 1,605 | 405 | 207 | 0 |
31 Dec 17 | 1,514 | 374 | 192 | 0 |
30 Sep 17 | 1,425 | 343 | 159 | 0 |
30 Jun 17 | 1,303 | 292 | 174 | 0 |
31 Mar 17 | 1,237 | 276 | 166 | 0 |
31 Dec 16 | 1,171 | 260 | 159 | 0 |
30 Sep 16 | 1,116 | 247 | 264 | 0 |
30 Jun 16 | 1,074 | 251 | 281 | 0 |
31 Mar 16 | 1,044 | 198 | 272 | 0 |
31 Dec 15 | 1,015 | 145 | 264 | 0 |
30 Sep 15 | 980 | 134 | 121 | 0 |
30 Jun 15 | 937 | 93 | 127 | 0 |
31 Mar 15 | 898 | 113 | 124 | 0 |
31 Dec 14 | 860 | 133 | 121 | 0 |
30 Sep 14 | 807 | 105 | 92 | 0 |
31 Dec 13 | 672 | 62 | 92 | 0 |
Quality Earnings: IDHC has a high level of non-cash earnings.
Growing Profit Margin: IDHC's current net profit margins (17.2%) are higher than last year (12.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IDHC's earnings have grown by 3.9% per year over the past 5 years.
Accelerating Growth: IDHC's earnings growth over the past year (80.9%) exceeds its 5-year average (3.9% per year).
Earnings vs Industry: IDHC earnings growth over the past year (80.9%) exceeded the Healthcare industry -0.8%.
Return on Equity
High ROE: IDHC's Return on Equity (20.6%) is considered high.